Sandu Pharmaceuticals Q4 Results

  • BSE: 524703
  • NSE: -
  • ISIN: INE751D01014
  • Sector: Biotechnology & Drugs
BSE
57.820.02 (0.03%)
Volume1.30 K
Updated: Tue 26 Nov, 2024 | 15:21:03
NSE
This stock is not traded on NSE
Today: 57.00
59.15
52-Wk: 54.00
85.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sandu Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 15.6017.09-%15.26-%
    Selling/ General/ Admin Expenses Total 2.472.86-%3.07-%
    Depreciation/ Amortization 0.190.13-%0.13-%
    Other Operating Expenses Total 6.325.94-%5.49-%
    Total Operating Expense 15.1816.40-%14.92-%
    Operating Income 0.420.69-%0.35-%
    Net Income Before Taxes 0.720.70-%0.38-%
    Net Income 0.590.48-%0.27-%
    Diluted Normalized EPS 0.620.51-%0.27-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts